breast cancer
-
Roche India launched PHESGO, therapy for breast cancer
The first ever fixed dose formulation in oncology to combine two monoclonal antibodies – Perjeta (pertuzumab) and Herceptin Roche Pharma…
Read More » -
Niramai partners with Healthians for breast cancer screening
The partnership will leverage Niramai’s radiation-free technology to make women more aware of their breast health Niramai has partnered with…
Read More » -
APCC organises second edition of breast oncology conference
More than 40 senior doctors from various parts of the world attended the two-day virtual conference Apollo Proton Cancer Centre…
Read More » -
Cancer screening among women drop drastically due to covid fears
Only 25 per cent women are aware of the disease and preventive care measures, according to the doctors Owing to…
Read More » -
Pakistan leads in highest rate of breast cancer in Asia: Report
According to a media release, one in 10 Pakistani women could develop breast cancer in their lifetime Pakistan has the…
Read More » -
Alembic Pharma gets US FDA nod for breast cancer drug
The approved product is therapeutically equivalent to the reference listed drug product lbrance Capsules of Pfizer Alembic Pharmaceuticals has received…
Read More » -
Neuberg Diagnostics conducts survey on breast cancer
According to the survey, 70 percent of women are aware of the self-examination of breast cancer out of which 56…
Read More » -
MyGate joins hands with Niramai
The partnership will also see MyGate hosting a webinar and live Q&A on breast cancer exclusively for its customers In…
Read More » -
Simulations of breast tissue address delay on enhanced MRI cancer detection
Purdue University researchers have simulated over 20 different breast tissue ratios respond to heat given off by MRIs at higher…
Read More » -
Study says Burden of Hereditary Cancer is 3-times Higher in India
Strand Life Sciences, Bangalore based genetic diagnostics company released the findings of their extensive retrospective research analysis conducted on Breast…
Read More »
